News
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
A pharmacist holds boxes of Ozempic, a semaglutide injection drug made by Novo Nordisk, in Provo, Utah, on March 29, 2023.
Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, ...
Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...
The brain busting side-effects of Ozempic-like fat jabs revealed – ‘slashing risk of silent killers’
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
John Goodman smiled away on the red carpet, showing off just how far he has come in his weight loss journey. The actor voiced ...
I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for ...
It feels like Mounjaro is everywhere, and one TikTok star has been sharing the true nature of using it for weight loss ...
GLP-1 medications work by mimicking a hormone that regulates blood sugar, suppresses appetite and slows digestion, which in turn is said to 'reduce food noise,' particularly for those who struggle ...
3h
Zacks Investment Research on MSNNovo Nordisk Plunges 20% YTD: How Should Investors Play the Stock?Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...
Innovent Biologics, the first Chinese firm to gain approval for a GLP-1 weight loss and diabetes drug, has partnered with JD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results